4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-18-054397
Director bought 7,100 shares at $14.00 ($99,370)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tullman Stephen A. Director | 2018-10-04 | Purchase | +7,100 | $14.00 | $99,370 | 177,457 | D |
| Open-market purchases · 7,100 sh · avg $14.00 · $99,370 | |||||||
Loading xslF345X03/doc4.xml…